MYCOTOXICOSIS

MYCOTOXICOSIS was reported 45 times

MYCOTOXICOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Plasma Kallikrein Inhibitor [EPC] 1 0.0004
1 Bismuth [EPC] 1 0.0002
2 Adenosine Receptor Agonist [EPC] 1 0.0001
3 Recombinant Human Growth Hormone [EPC] 2 0.0001
4 Provitamin D2 Compound [EPC] 2 0.0001
5 Interleukin-17A Antagonist [EPC] 1 0.0000
6 Anti-IgE [EPC] 2 0.0000
7 Copper-containing Intrauterine Device [EPC] 1 0.0000
8 Interleukin-23 Antagonist [EPC] 2 0.0000
9 Macrolide Antimicrobial [EPC] 1 0.0000
10 Nicotinic Acid [EPC] 1 0.0000
11 Nitroimidazole Antimicrobial [EPC] 1 0.0000
12 Non-Standardized Chemical Allergen [EPC] 1 0.0000
13 Arteriolar Vasodilator [EPC] 1 0.0000
14 Phosphodiesterase 4 Inhibitor [EPC] 2 0.0000
15 Amide Local Anesthetic [EPC] 1 0.0000
16 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
17 Interferon beta [EPC] 2 0.0000
18 Antiarrhythmic [EPC] 1 0.0000
19 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
20 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
21 Proteasome Inhibitor [EPC] 1 0.0000
22 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
23 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
24 Vitamin C [EPC] 3 0.0000
25 Janus Kinase Inhibitor [EPC] 1 0.0000
26 Estrogen [EPC] 1 0.0000
27 Expectorant [EPC] 1 0.0000
28 Thiazide Diuretic [EPC] 1 0.0000
29 Mood Stabilizer [EPC] 1 0.0000
30 Anti-epileptic Agent [EPC] 1 0.0000
31 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
32 Vitamin D [EPC] 1 0.0000
33 Vitamin B12 [EPC] 1 0.0000
34 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
35 Benzodiazepine [EPC] 2 0.0000
36 Corticosteroid [EPC] 3 0.0000
37 Loop Diuretic [EPC] 1 0.0000
38 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
39 Proton Pump Inhibitor [EPC] 1 0.0000
40 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000